恶性骨形成新生体与NIPBL::BEND2融合
Nooshin K Dashti1,2, George Matcuk3, Abbas Agaimy4
1Department of Pathology and Laboratory Medicine, Dartmouth Health Medical Center, Lebanon, New Hampshire, USA.
Genes, chromosomes & cancer
|November 28, 2024
概括
这项研究报告了一名年轻男子患有异常NIPBL::BEND2基因融合的罕见,侵袭性骨癌. 分子分析证实它是高等级的骨肉瘤,而不是化介质瘤,强调在具有挑战性的骨瘤病例中需要进行遗传检测.
科学领域:
- 整形瘤学 整形瘤学
- 骨病理学 骨病理学
- 分子诊断学 分子诊断
背景情况:
- 传统的高等级骨髓瘤具有攻击性特征,但罕见的变体表现出不寻常的组织学,需要分子确认.
- 硬化或类似骨质母细胞瘤的骨质沙尔科马由于非特异性组织病理学而具有诊断挑战性.
- 准确的诊断对于骨瘤的适当管理和预后至关重要.
研究的目的:
- 描述一种具有异常初始呈现和本位病理学特征的侵袭性骨形成瘤.
- 确定瘤的分子驱动因素,并确定其精确的分类.
- 为了评估这种罕见的骨髓瘤亚型的临床行为和治疗反应.
主要方法:
- 瘤活检和手术切除样本的组织病理学检查.
- 对于SATB2.2.的免疫组织化学.
- 用RNA测序来识别基因融合 (NIPBL::BEND2).
- 在FGF23.23的现场杂交.
- 用无监督聚类和UMAP分析进行DNA甲基化分析.
主要成果:
- 该瘤最初呈现为模仿骨质母细胞瘤的硬化性病变,但在攻击性地复发.
- 组织学演变为高度骨髓瘤,具有蕾丝状的骨状沉积和均的上皮状细胞.
- 分子分析揭示了NIPBL::BEND2的融合,此前与酸介质瘤 (PMT) 有关.
- DNA甲基化分析证实了瘤的分类为高度骨髓瘤,与PMT不同.
- 患者在膝下截肢后的化疗后实现了疾病缓解.
结论:
- NIPBL::BEND2融合可以发生在侵略性,高度骨髓瘤中,扩大其已知的光谱.
- 分子分析对于精确诊断具有挑战性的骨瘤至关重要,将其与PMT等实体区分开来.
- 这一案例凸显了不同类型的骨瘤中复发性融合的潜力,并强调了进一步研究的必要性.
更多相关视频
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.9K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K